Quality assurance of drugs used in clinical trials: proposal for adapting guidelines
Main Authors: | Newton, PN, Schellenberg, D, Ashley, EA, Ravinetto, R, Green, MD, ter Kuile, FO, Tabernero, P, White, NJ, Guerin, PJ |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BMJ Publishing Group
2015
|
Similar Items
-
WHO COVID-19 therapeutic guidelines – authors' reply
by: White, NJ, et al.
Published: (2021) -
Guidelines should not pool evidence from uncomplicated and severe COVID-19
by: White, NJ, et al.
Published: (2021) -
Quality assurance systems of pharmaceutical distributors in low-income and middle-income countries: weaknesses and ways forward
by: Nebot Giralt, A, et al.
Published: (2020) -
Febrile illness mapping-much of the world without data and without evidence-based treatments
by: Newton, PN, et al.
Published: (2020) -
Proposing Guidelines for Improving Information Assurance Awareness based on Information Security Awareness Measurement Framework /
by: Heng, Shun Ling, author, et al.
Published: (2015)